| | |
| Clinical data | |
|---|---|
| Trade names | Celospor, Celtol, Cristacef |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Intravenous, intramuscular, intramammary |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 23 to 38% |
| Elimination half-life | 1.2 hours |
| Excretion | Renal (72%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.030.449 |
| Chemical and physical data | |
| Formula | C13H13N3O6S |
| Molar mass | 339.32 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in gram-positive and gram-negative bacterial infections. It is a bacteriostatic antibiotic. [1] [2] Cefacetrile is marketed under the trade names Celospor, Celtol, and Cristacef, [3] and as Vetimast for the treatment of mammary infections in lactating cows. [2]
It was made by reacting 7-ACA (7-aminocephalosporanic acid) with cyanoacetyl chloride in the presence of tributylamine.[ citation needed ]